Hint Health Launches New AI Product
Hint Health is aiming to reshape the doctor-patient relationship with an AI product made in collaboration with OpenAI. By providing AI tools to the thousands of Direct Primary Care (DPC) doctors on the Hint platform, this integration aims to help practitioners use technology to amplify their care rather than replace it.
Hint’s platform, All-in-One, launched a Beta portion of the app with the ability to record patient consultations or interactions, transcribe them using the OpenAI Whisper API, then automatically generate documentation on behalf of the clinician using OpenAI’s large language models. As the first in many planned features on Hint’s platform, this application frees up significant time for the doctor to practice medicine, focus on their patients, and grow their business, instead of taking notes.
“Our vision is a future where technology empowers, rather than hinders, the doctor-patient relationship,” said Zak Holdsworth, CEO of Hint Health. “The technological arms race in insurance-based care models has for decades led to systematically worse access and experience for patients and doctors, and Direct Primary Care is reversing this trend. This product launch is exciting because in the hands of the DPC community, we believe AI has the potential to help restore trust and integrity in our healthcare systems.”
While the mainstream healthcare system, built on antiquated insurance fee-for-service models, may see AI as a means to automate away the doctor, the community of clinicians on the Hint platform work outside this status quo and entered this collaboration with the mission of ensuring AI is used with the right intentions in healthcare.
Citrus Health Group Acquires MedLogix Communications
Citrus Health Group, LLC and NaviMed Capital have acquired MedLogix Communications, a full-service medical communications company founded in 2000 by Susan Sessa and Jeff Debs, PharmD to provide scientific and medical communications and engaging meetings and events services to the pharmaceutical, biotechnology, and medical device industries.
Sessa will join the Citrus Health Executive Board as Chief Operating Officer and Debs will become Executive VP, Medical Consulting. They’ll be trusted to continue their client relationships and deliver high-quality scientific content, meetings, and events services.
“We are excited to add MedLogix to the Citrus Health family,” stated Neil Matheson CEO, Citrus Health Group. “Sue and Jeff have built a talented team of scientific communications, medical affairs, and meeting and event professionals and they have an enviable reputation for high-quality scientific strategy and excellence in tactical implementation.”
EVERSANA Unveils New Patient Support Platforms
EVERSANA, a leader in commercialization services to the global life sciences industry, has unveiled ACTICS eAccess, a powerful, proprietary electronic benefits verification (eBV) and electronic prior authorization (ePA) platform. In order to advance patient support, this first-to-market technology gives patient service teams nearly immediate insight into patient coverage from both pharmacy and major medical plans, any potential need for prior authorization support, and any financial responsibilities impacting patient access and speed to treatment. With 90% accuracy, ACTICS eAccess leverages EVERSANA’s digital connectivity to more than 1,400 payers across the U.S. and integrates data from more than 90% of covered lives to verify pharmacy and major medical plan coverage nearly immediately.
“Current eBV and ePA tools fail to meet the needs of patients. In many cases only 60% of the electronic verification results are accurate and more than 70% of prior authorization submissions are rejected with little to no reporting on the patient’s status. Delays like that add to an already lengthy treatment journey, forcing patients to wait,” said Jim Lang, CEO, EVERSANA. “Backed with the most reliable patient support service teams in the industry, we invested in the solution. And it works in seconds—not days.”
This platform allows the doctor’s office to do it all in one place—ACTICS eAccess’ insight into major medical plans, patients, and providers can determine patient-specific out-of-pocket costs, patient deductibles, and coverage for physician-administered drugs, buy and bill, as well as ancillary services. Providers can compare coverage and out-of-pocket costs between pharmacy and medical to identify the best reimbursement pathway for the patient. Finally, next-generation technology expedites the prior authorization submission process, delivering a much higher percentage of accepted submissions by insurance providers.
Introducing iCliniq Engage Telehealth Advertising Solutions
iCliniq, a healthcare resource provider operating in the U.S., U.K., UAE, India, Singapore, and Germany, launched new offerings on iCliniq Engage, its suite of contextual advertising engagement solutions for pharmaceutical and medical advertisers. The telehealth solutions offered include targeted display of video ads on more than 50,000 pieces of original, medically reviewed, high-intent, contextually relevant health content pieces within iCliniq’s health articles, telehealth Q&As, and health tools, as well as asynchronous and synchronous consultation waiting rooms. iCliniq allows pharma companies to add the benefits of a treatment and can provide video and infographic content at the point of care.
“Each month, iCliniq attracts more than 700,000 unique patients, and they’re on a mission to find answers related to specific medical conditions,” said Dhruv Suyamprakasam, CEO of iCliniq. “By incorporating relevant medical advertisements alongside corresponding iCliniq content pages, we’re able to help pharma marketers get the precisely right messaging in front of appropriate patients, at the point of interest. We’re proud to be offering a targeted approach to pharmaceutical marketing.”
This iCliniq Engage update builds on the company’s existing offerings in the U.S., which includes the recently launched, real-time asynchronous consultations with primary care physicians and second opinion telehealth visits.
Interpublic Group Updates Golin Health
Interpublic Group is updating the brand identity of its agency Golin Health, reflecting its global healthcare capabilities and its mission of “working to bring health within reach for more.” The new brand identity comes with new creative, digital, and social assets.
“With an increasing portfolio and an impact in numerous therapeutic areas, Golin Health has released a new website and brand identity that supports its critical mission and values of working to bring health within reach for more,” said Cori McKeever, President, Global Healthcare, Golin. “The new branding is rooted in Golin’s master values to discover powerful human truths that bind us, to create with bravery, and to collaborate inclusively and obsessively, but it brings a specialized focus on the important healthcare issues that matter to our clients and are backed by the expertise of our specialists.”
The brand identity is featured on GolinHealth.com, as well as Golin Health’s dedicated LinkedIn and Instagram channels. Using data-driven strategies, deep scientific knowledge, and cultural connections, Golin Health creates attention-grabbing work that drives change. A selection of work is featured on the new website, as well as news and perspectives from the talent that comprises the agency. Golin’s extensive work in the healthcare industry has generated significant annual double-digit growth in recent years, and it accounts for nearly 25% of the agency’s overall global revenue.
“Golin Health’s new brand identity and strong mission supports our culture of creating change that matters, and we are energized by the opportunities the future holds to continue to make a difference in peoples’ lives,” said Matt Neale, CEO, Golin. “At its core, Golin Health believes everyone should have access to the information they need to make informed healthcare decisions and is on a mission to help its clients achieve this goal.”
